Pallidin Activators
Pallidin activators encompass a diverse range of chemical compounds that exert their effects through unique and specific signaling pathways or biological processes. One of the main mechanisms that can enhance the functional activity of Pallidin involves the regulation of protein kinases and phosphatases. Compounds like Rottlerin, and Forskolin act on these proteins to indirectly enhance the activity of Pallidin. These compounds inhibit or activate specific kinases, altering the competition for binding sites or affecting the phosphorylation status of Pallidin, leading to its activation.
Another significant group of Pallidin activators are those that affect cellular structures or processes in which Pallidin is involved. Vinblastine, 2-Deoxy-D-glucose, Chlorpromazine, MβCD, Brefeldin A, and Nocodazole exert their effects on microtubule dynamics, glycolysis, clathrin-mediated endocytosis, cholesterol levels in the plasma membrane, the Golgi apparatus, and vesicle trafficking, respectively.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calmodulin (human), (recombinant) | 73298-54-1 | sc-471287 | 1 mg | $300.00 | ||
Calmodulin is a calcium-binding messenger protein. Pallidin is known to interact with calmodulin-dependent proteins, and its activity can be enhanced by increases in intracellular calcium levels caused by calmodulin. | ||||||
Rottlerin | 82-08-6 | sc-3550 sc-3550B sc-3550A sc-3550C sc-3550D sc-3550E | 10 mg 25 mg 50 mg 1 g 5 g 20 g | $84.00 $166.00 $302.00 $2091.00 $5212.00 $16657.00 | 51 | |
Rottlerin is a PKCδ inhibitor. PKCδ is another protein that Pallidin interacts with. By inhibiting PKCδ, Rottlerin can increase Pallidin's relative activity by reducing competition for binding sites. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of Protein Kinase C (PKC). Pallidin, as a known interactor with PKC, can have its functionality enhanced by PMA through the increased activity of PKC. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases. By inhibiting these phosphatases, okadaic acid can enhance the phosphorylation status of Pallidin, leading to its activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased cAMP levels. cAMP can enhance the activity of Pallidin by activating PKA, which can phosphorylate and activate Pallidin. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine disrupts microtubule dynamics. Pallidin is part of the BLOC-1 complex which is associated with tubular endosomes, thus vinblastine can logically enhance Pallidin activity by affecting endosome dynamics. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
As an inhibitor of glycolysis, 2-Deoxy-D-glucose can alter cellular energy status and thus can influence Pallidin's activity within the BLOC-1 complex and endosomal trafficking. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine affects clathrin-mediated endocytosis, a process in which Pallidin is involved through the BLOC-1 complex. It can logically enhance Pallidin activity by influencing endosomal trafficking. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
MβCD depletes cholesterol from the plasma membrane. Pallidin's function in endosomal trafficking can be enhanced by membrane fluidity changes from MβCD treatment. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus and affects vesicle trafficking. As Pallidin is involved in vesicle trafficking, its activity can be logically enhanced by Brefeldin A. | ||||||